Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Proton pump inhibitors: an update.

Vanderhoff BT, Tahboub RM.

Am Fam Physician. 2002 Jul 15;66(2):273-80.

2.

An overview of proton pump inhibitors.

Der G.

Gastroenterol Nurs. 2003 Sep-Oct;26(5):182-90. Review.

PMID:
14603076
3.

Proton pump inhibitors.

Grover JK, Vats V.

Trop Gastroenterol. 1999 Jan-Mar;20(1):16-28. Review. No abstract available.

PMID:
10464444
4.

Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.

Hatlebakk JG, Berstad A.

Clin Pharmacokinet. 1996 Nov;31(5):386-406. Review.

PMID:
9118586
5.

Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.

Welage LS, Berardi RR.

J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. Review.

PMID:
10665250
6.
7.
8.

The clinical importance of proton pump inhibitor pharmacokinetics.

Yacyshyn BR, Thomson AB.

Digestion. 2002;66(2):67-78. Review.

9.

Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.

Miner P Jr, Katz PO, Chen Y, Sostek M.

Am J Gastroenterol. 2003 Dec;98(12):2616-20.

PMID:
14687806
10.

Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.

Kromer W, Horbach S, Lühmann R.

Pharmacology. 1999 Aug;59(2):57-77. Review.

PMID:
10450061
11.

[2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].

Leonhardt U, Ritzel U, Ramadori G.

Internist (Berl). 1996 Sep;37(9):944-9; discussion 949. German. No abstract available.

PMID:
8964694
12.

Shortcomings of the first-generation proton pump inhibitors.

Tytgat GN.

Eur J Gastroenterol Hepatol. 2001 May;13 Suppl 1:S29-33. Review.

PMID:
11430506
13.

The pharmacology and clinical relevance of proton pump inhibitors.

Katz PO, Frissora C.

Curr Gastroenterol Rep. 2002 Dec;4(6):459-62. Review.

PMID:
12441035
14.

[All proton pump inhibitors are equally efficacious in standard dosages].

Hellström PM, Vitols S.

Lakartidningen. 2003 Jun 19;100(25):2212-6. Review. Swedish.

PMID:
12872509
15.

Safety of proton pump inhibitors--an overview.

Arnold R.

Aliment Pharmacol Ther. 1994;8 Suppl 1:65-70. Review.

PMID:
8180297
16.

[H2 receptor antagonists and proton pump inhibitors: principles and rules of use].

Bardou M.

Rev Prat. 2001 Apr 15;51(7):789-95. Review. French. No abstract available.

PMID:
11387678
17.

Pantoprazole, Prout and the proton pump.

Playford RJ, Podas T, Modlin I.

Hosp Med. 1999 Jul;60(7):500-4. Review.

PMID:
10605542
18.

[Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease].

Maev IV, Balashova NN, Busarova GA.

Klin Med (Mosk). 2003;81(9):54-9. Review. Russian.

PMID:
14598594
19.

Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management.

Orr WC.

Eur J Gastroenterol Hepatol. 2005 Jan;17(1):113-20. Review.

PMID:
15647651
20.

The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study.

Diav-Citrin O, Arnon J, Shechtman S, Schaefer C, van Tonningen MR, Clementi M, De Santis M, Robert-Gnansia E, Valti E, Malm H, Ornoy A.

Aliment Pharmacol Ther. 2005 Feb 1;21(3):269-75.

Supplemental Content

Support Center